Editorial Staff

Editor Barbara Zeiger

Assistant Editor Lauren Mateja

Web Content Coordinator Katherine Blessing

Editorial Correspondence

Barbara Zeiger, Editor, OWM

HMP Communications, 70 E Swedesford Rd
Suite 100, Malvern PA, 19355

Telephone: (800) 237-7285 or
(610) 560-0500, ext. 4244
Fax: (610) 560-0501

Email: bzeiger@hmpcommunications.com

December 2012 | Volume 58 - Issue 12

A Randomized, Controlled Study to Assess the Effect of Silk-like Textiles and High-absorbency Adult Incontinence Briefs on Pressure Ulcer Prevention


  Pressure ulcer prevention is an important aspect of nursing home care. A 20-week, unblinded, randomized, controlled trial was conducted to compare the rate of nursing home-acquired pressure ulcers and adverse events between residents managed using: 1) a silk-like textile for bedding paired with high-absorbency adult incontinence briefs or 2) usual-care, plain-weave cotton/polyester bed sheets and adult incontinence briefs....

A Budget Impact Analysis Comparing Use of a Modern Fecal Management System to Traditional Fecal Management Methods in Two Canadian Hospitals


  Research suggests that fecal management systems (FMS) offer advantages, including potential cost savings, over traditional methods of caring for patients with little or no bowel control and liquid or semi-liquid stool. A budget impact model accounting for material costs of managing fecal incontinence was developed, and 1 year of experiential data from two hospitals’ ICUs were applied to it....

Peristomal and Generalized Bullous Pemphigoid in Patients with Underlying Inflammatory Bowel Disease: Is Plectin the Missing Link?


  Bullous pemphigoid (BP) is a blistering disorder of the skin and mucosa that may coexist with inflammatory bowel disease (IBD). The authors’ experiences with peristomal and generalized BP in five patients (three with ulcerative colitis [UC] post colostomy surgery and two with Crohn’s disease [CD] post ileostomy surgery, time since surgery 5 to 20 years) is described....

Guest Editorial: Surfing an Ocean of Change

  Despite the challenges of cost and other resource constraints, advancements in continence care continue to bring new options through technology, research, and the innovative spirit of American ingenuity. New medications for overactive bladder (OAB), new devices that assess and treat fecal and urinary incontinence, more absorbent products, and most importantly, ongoing education and research lend hope to persons coping with incontinence and those who provide and champion their care. A Google search using the phrase incontinence technology yielded the following recent advancements. ...

Letter to the Editor: Pressure Ulcers: The Role of Thermography and the Need to Revisit Staging

  Regarding the article, Farid et al. Using temperature of pressure-related intact discolored areas of skin to detect deep tissue injury: an observational, retrospective, correlational study. Ostomy Wound Manage. 2012;58(8):20–31: The article was a single-institution retrospective review of pressure-related color changes in the setting of intact skin.

  With respect to the staging system, the National Pressure Ulcer Advisory Panel follows the scientific process. As such, change is warranted based on robust and confirmed research. Also, any definition meant for widespread use must walk the line between comprehension and comprehensiveness....

Continence Coach: Calling on Cotton for Innovative Perineal Care

  Innovation in product design can sometimes happen in small, evolutionary steps or in huge, discontinuous leaps. It can be heralded by new technology or by new understanding of the product’s use or user needs. Innovation may involve something greater than the user, such as sustaining a stronger environment. One of many definitions of innovation describes it from the commercial perspective as a replicable idea that has value in the marketplace.1 For me, a primary reward of working in the healthcare sector is its openness to change through innovation and the dogged determination of its highly diversified, interdisciplinary players — clinicians, researchers, educators, policy makers, and market makers — to improve the quality of care through innovative creativity....

Special to OWM: Support for Ostomy Patients: Friends of Ostomates Worldwide-USA

  Persons with an ostomy face numerous challenges and adjustments. Studies describe initial needs: a stoma site marked by an ostomy nurse specialist,1,2 a stoma designed with a protrusion to allow the stoma effluent to drain into the pouching system, education by a nurse specialist to acquire the skills necessary to manage the stoma,3 the help and support of a significant other,4 and an appropriate, predictable pouching system that provides security as well as protects the peristomal skin. The pouching system must be matched to the stoma size and shape and peristomal skin contours, and the correct wear time must be determined. The adaptation process may require the person with an ostomy to continually assess what system is appropriate for his/her needs. ...

My Scope of Practice: The Art of Listening

The most basic of all human needs is the need to understand and be understood. The best way to understand people is to listen to them. — Ralph Nichols, author

 Be patient, be kind, be helpful — words of wisdom that express how Christa M. Heinsler, RN/NP, CWOCN approaches her life and her work. As a wound, ostomy, and continence nurse, Christa, along with her colleagues, cares for patients who have not only a wound, but also, in many cases, a new lifestyle to manage. In such situations, nurses must treat the whole patient, helping them to physically and emotionally heal. As Christa has learned, sometimes the best way to help is to listen....

AAWC Update: Remembering a Year of Progress

 The AAWC would like to thank its members, volunteers, partners, and corporate sponsors for a prosperous 2012. Because of your financial and volunteer support, AAWC has been able to accomplish and provide the following:...

New Products and Industry News

Acquisition announced

  Smith & Nephew (Forth Worth, TX) will acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. The transaction is subject to regulatory approval and is expected to close in December 2012.

  Over the last several years, Healthpoint Biotherapeutics, founded in 1992 by Chairman and CEO Paul Dorman, has focused on biopharmaceutical leadership in acute, chronic, and burn-related wound care. Led by sales of Collagenase Santyl® ointment, the company has driven impressive growth in its commercial platform and laid the groundwork for strong future growth through development of a novel cell therapy, HP802-247, now in trials. ...